Kazia Therapeutics Ltd (KZIA) stock
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.49+0.18 (+3.39%)
Close on Nov 18, 2026Market cap $8.89MP/E –Yield –
Kazia Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -A$13.28M. The highest annual figure on record is -A$6.71M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | -A$13.28M | – |
| FY2024 | Jun 30, 2024 | -A$9.58M | – |
| FY2023 | Jun 30, 2023 | -A$15.16M | – |
| FY2022 | Jun 30, 2022 | -A$22.76M | – |
| FY2021 | Jun 30, 2021 | -A$9.11M | – |
| FY2020 | Jun 30, 2020 | -A$8.81M | – |
| FY2019 | Jun 30, 2019 | -A$6.71M | – |
| FY2018 | Jun 30, 2018 | -A$8.66M | – |
| FY2017 | Jun 30, 2017 | -A$11.44M | – |
| FY2016 | Jun 30, 2016 | -A$11.98M | – |
See a number that looks wrong?